|
Name |
3,4-Dimethoxyphenol
|
Molecular Formula | C8H10O3 | |
IUPAC Name* |
3,4-dimethoxyphenol
|
|
SMILES |
COC1=C(C=C(C=C1)O)OC
|
|
InChI |
InChI=1S/C8H10O3/c1-10-7-4-3-6(9)5-8(7)11-2/h3-5,9H,1-2H3
|
|
InChIKey |
SMFFZOQLHYIRDA-UHFFFAOYSA-N
|
|
Synonyms |
3,4-DIMETHOXYPHENOL; 2033-89-8; Phenol, 3,4-dimethoxy-; 3,4-Bis(methyloxy)phenol; 3,4-dimethoxy phenol; 38B43WCU83; MFCD00008390; 4-Hydroxyveratrole; NSC-140927; 3,4-dimethoxyphel; UNII-38B43WCU83; EINECS 217-995-4; NSC140927; 3,4,dimethoxyphenol; Phenol,4-dimethoxy-; NSC 140927; 3,4-dimethoxy-phenol; 3, 4-dimethoxy phenol; 3,4-Dimethoxyphenol, 97%; SCHEMBL119396; 1-hydroxy-3,4-dimethoxybenzene; DTXSID7062112; ZINC388573; ACT11670; CS-B1823; HY-N1780; STR06225; AKOS005146109; AC-3793; AM61832; SY017636; TS-02054; DB-031011; A4425; D3221; FT-0614348; EN300-91592; 033D898; AE-508/42302277; Q-101910; Q27256773
|
|
CAS | 2033-89-8 | |
PubChem CID | 16251 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 154.16 | ALogp: | 1.7 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 38.7 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.707 |
Caco-2 Permeability: | -4.463 | MDCK Permeability: | 0.00001930 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.515 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.015 |
Blood-Brain-Barrier Penetration (BBB): | 0.337 | Plasma Protein Binding (PPB): | 59.51% |
Volume Distribution (VD): | 1.216 | Fu: | 26.46% |
CYP1A2-inhibitor: | 0.839 | CYP1A2-substrate: | 0.917 |
CYP2C19-inhibitor: | 0.285 | CYP2C19-substrate: | 0.842 |
CYP2C9-inhibitor: | 0.037 | CYP2C9-substrate: | 0.899 |
CYP2D6-inhibitor: | 0.122 | CYP2D6-substrate: | 0.918 |
CYP3A4-inhibitor: | 0.071 | CYP3A4-substrate: | 0.281 |
Clearance (CL): | 11.846 | Half-life (T1/2): | 0.905 |
hERG Blockers: | 0.048 | Human Hepatotoxicity (H-HT): | 0.075 |
Drug-inuced Liver Injury (DILI): | 0.197 | AMES Toxicity: | 0.026 |
Rat Oral Acute Toxicity: | 0.091 | Maximum Recommended Daily Dose: | 0.072 |
Skin Sensitization: | 0.778 | Carcinogencity: | 0.287 |
Eye Corrosion: | 0.914 | Eye Irritation: | 0.978 |
Respiratory Toxicity: | 0.379 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000712 | 0.585 | D0E9CD | 0.429 | ||||
ENC000478 | 0.585 | D09GYT | 0.429 | ||||
ENC000168 | 0.579 | D0Q9ON | 0.418 | ||||
ENC001461 | 0.571 | D02XJY | 0.362 | ||||
ENC000499 | 0.545 | D06GCK | 0.356 | ||||
ENC001363 | 0.521 | D0E6OC | 0.347 | ||||
ENC002891 | 0.512 | D01SAT | 0.329 | ||||
ENC000172 | 0.462 | D0NJ3V | 0.312 | ||||
ENC005746 | 0.451 | D0S5LH | 0.292 | ||||
ENC000304 | 0.444 | D0F4ZY | 0.289 |